Locations
New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series C+
founded in
2010
Inspirna is a clinical-stage biopharmaceutical company focused on developing first-in-class cancer therapeutics targeting previously untreatable common cancers. Utilizing its proprietary RNA-DRIVEr™ platform, Inspirna identifies novel cancer drivers and develops small molecules and biologics to address significant unmet medical needs. The company is advancing a pipeline that includes oral small molecules in various stages of clinical development for cancers such as RAS mutant colorectal cancer and non-small cell lung cancer. Inspirna aims to provide practical treatment options that enhance patient survival and quality of life, positioning itself as a key player in the oncology market.
Something looks off?